Gabales, Lulito, JR.. C.

HRN: 24-89-78  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/11/2024
06/18/2024
IV
500mg
Q8H
S/P ExLap
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: